Schedule 13G ownership disclosure
Opus Genetics, Inc.
Security class unavailable · CUSIP: 67577R102
Event date: 2020-11-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 779,993
- Percent of class
- 7.1360%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000897101-21-000241
- Form type
- SC 13G
- Filer
- Apexian Pharmaceuticals, Inc.
- CIK
- CIK 1560913
- Filed
- Mar 26, 2021
- Reporting period
- Nov 06, 2020
- Description
- Schedule 13G beneficial ownership